# Beam Therapeutics Inc.: Form DEF 14A, filed Apr 22, 2022

- Company: [Beam Therapeutics Inc.](/companies/beam.md) (CIK 1745999)
- Form: DEF 14A
- Filed: 2022-04-22
- Accepted by EDGAR: Apr 22, 2022, 16:24 ET
- Period: 2022-06-08
- Accession: 0000950170-22-006016
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1745999/000095017022006016/beam_2022_notice_and_pro.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1745999/000095017022006016/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1745999/000095017022006016/beam_2022_notice_and_pro.htm

Filed Apr 22, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-006016. Last ingested by Listed: Nov 14, 2026, 12:58 ET. No prices; not investment advice.
